Stay updated on Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.

Latest updates to the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page
- Check4 days agoChange DetectedA new page revision tag Revision: v3.6.3 has been added. The condition label 'Type 2 diabetes' and the related topics 'MedlinePlus Genetics' were removed, and the older revision tag Revision: v3.6.1 was dropped.SummaryDifference0.2%

- Check11 days agoChange DetectedRevision tag at the bottom of the page updated from v3.6.0 to v3.6.1, indicating a newer build of the page. This update does not alter study data, eligibility criteria, or how the page functions.SummaryDifference0.0%

- Check20 days agoChange DetectedThe study page now shows that recruitment is closed and no participants are being sought. New help/navigation items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, along with a revision note (Revision: v3.6.0).SummaryDifference0.5%

- Check28 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a small update to the page metadata or content.SummaryDifference0.1%

- Check42 days agoChange DetectedType 2 diabetes was added to the study keywords/MeSH terms, and a related topics entry for MedlinePlus Genetics was introduced. These additions improve discoverability and provide consumer health context without altering the main study content.SummaryDifference0.2%

- Check49 days agoChange DetectedRevision updated to v3.5.4. The 'Type 2 diabetes' condition and the 'MedlinePlus Genetics' related topics were removed from the study record.SummaryDifference0.2%

Stay in the know with updates to Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.